Literature DB >> 12488280

Visual symptoms in patients on cyclophosphamide may herald sight threatening disease.

A Agrawal, A D Dick, J A Olson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12488280      PMCID： PMC1771481          DOI： 10.1136/bjo.87.1.122

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

Review 1.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.

Authors:  K V Komanduri; M N Viswanathan; E D Wieder; D K Schmidt; B M Bredt; M A Jacobson; J M McCune
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

3.  Cytomegalovirus retinitis in the presence of a normal helper T-cell count.

Authors:  D A Morrison; K Bibby; M Wiselka; A R Rosenthal
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

4.  Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus.

Authors:  R O Schlingemann; P Wertheim-van Dillen; A Kijlstra; P J Bos; C Meenken; E J Feron
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

5.  Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

Authors:  A Erice; M C Jordan; B A Chace; C Fletcher; B J Chinnock; H H Balfour
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

6.  Cytomegalovirus retinitis in a patient with Wegener's granulomatosis.

Authors:  I Tugal-Tutkun; N Kir; A Gül; M Koniçe; M Urgancioglu
Journal:  Ophthalmologica       Date:  2000       Impact factor: 3.250

7.  Maintenance of replicative intermediates in ganciclovir-treated human cytomegalovirus-infected retinal glia.

Authors:  E M Burd; J S Pulido; D G Puro; W J O'Brien
Journal:  Arch Ophthalmol       Date:  1996-07

8.  Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.

Authors:  B D Kuppermann; J G Petty; D D Richman; W C Mathews; S C Fullerton; L S Rickman; W R Freeman
Journal:  Am J Ophthalmol       Date:  1993-05-15       Impact factor: 5.258

9.  CD8+ T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

Authors:  C Y Lowder; C P Butler; E M Dodds; M Secic; C Recillas-Gispert
Journal:  Am J Ophthalmol       Date:  1995-09       Impact factor: 5.258

10.  Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.

Authors:  T R Vrabec; V F Baldassano; S M Whitcup
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.